• Avidity Biosciences EPS for the quarter ending September 30, 2024 was $-0.65, a 8.45% decline year-over-year.
• Avidity Biosciences 2023 annual EPS was $-2.91, a 12.87% decline from 2022.
• Avidity Biosciences 2022 annual EPS was $-3.34, a 17.19% increase from 2021.
• Avidity Biosciences 2021 annual EPS was $-2.85, a 39.02% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.